is zepbound a glp 1 medication Researchers move closer to matching patients with GLP-1 drug that works best for them Eli Lilly strikes Zepbound deal

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns.In December, the FDA released a statement to health care professionals and patients warning against the use of compounded and counterfeit versions of diabetes and obesity drugs, including semaglutide (Ozempic/Wegovy, Novo

Lets start with the short summary (longer explanation below): SUPPORT GLP-1 PRODUCTION: In clinical studies Eriomins patented lemon bioflavonoid complex is shown to promote increased GLP-1 levels and support metabolic health.* GLP-1 Daily does not contain GLP-1 or synthetic GLP-1 and is not a GLP-1 agonist drug

however, this contradicts established trial data favoring SGLT2 inhibitors for heart failure and should be interpreted cautiously due to possible residual confounding

This supports that pharmacies are permitted to compound GLP-1 drugs under section 503A of the Act, provided they adhere to specific conditions outlined by the FDA